Synapsoft logo
AI Insights from Disclosures
Searching...
CKD Bio Corp. 063160
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
CKD Bio Corp. was spun off and newly established from CKD Pharmaceutical Corporation's active pharmaceutical ingredient business division in November 2001, and operates an advanced integrated fermentation facility on a 51,473.2 square meter site in Ansan, exporting more than 30 types of active pharmaceutical ingredients and finished products worldwide, including to the United States, Southeast Asia, China, Latin America, the Middle East, Europe, and Africa. The company's main production items include active pharmaceutical ingredients such as Potassium Clavulanate, DMCT, Rifamycin O, and Acarbose, used in antibiotics, diabetes treatments, irritable bowel syndrome treatments, and immunosuppressants, and it has recently been putting great effort into the research and development of high-value-added new products targeting developed country markets.
Representative Director Park Wangap
Founded November 12, 2001
Corporation Type KOSPI
Industry Classification Manufacture of medicaments
Corporate number 11011-2373308
Business number 110-81-53652
Phone Number 02-2194-0555
Fax Number 02-2194-0556
Website www.ckdbio.com
Company Address 8 Chungjeong-ro, Seodaemun-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant